Osteochondromatosis

Search Trials
Phase I Trial of Vorinostat (MK-0683, SAHA) in Combination With Decitabine in Patients With AML or MDS (MK-0683-055 EXT1)
Status:
Completed
Last Changed:
Jan 1, 1970
First Changed:
Jan 1, 1970
Disease(s):
Leukemia, Myelocytic, Acute Myelodysplastic Syndromes
Intervention(s):
vorinostatdecitabine
Suberoylanilide Hydroxamic Acid (Vorinostat, MK-0683) Versus Placebo in Advanced Malignant Pleural Mesothelioma (0683-014 AM5, EXT1)
Status:
Completed
Last Changed:
Jan 1, 1970
First Changed:
Sep 8, 2005
Disease(s):
Mesothelioma
Intervention(s):
vorinostatPlacebo
Vorinostat (MK-0683) Phase I Study in Cutaneous T-Cell Lymphoma (CTCL) Patients (MK-0683-089 EXT1)
Status:
Completed
Last Changed:
Jan 1, 1970
First Changed:
Jan 1, 1970
Disease(s):
Lymphoma
Intervention(s):
vorinostat
Safety and Tolerability Study for the Pneumococcal Conjugate Vaccine V114 Versus Prevnar™ (V114-001 EXT1)(COMPLETED)
Status:
Completed
Last Changed:
Jan 1, 1970
First Changed:
Jun 10, 2010
Disease(s):
Pneumococcal Vaccines
Intervention(s):
Adults-Adjuvanted V114Adults-Prevnar™Toddlers-Adjuvanted V114Toddlers-Non-adjuvanted V114Toddlers-Prevnar™
Phase 1 Study of Vorinostat and Bortezomib in Multiple Myeloma (MK-0683-015 EXT 1 (AM1))
Status:
Completed
Last Changed:
Jan 1, 1970
First Changed:
Jan 1, 1970
Disease(s):
Multiple Myeloma
Intervention(s):
vorinostatbortezomib

Connect. Empower. Inspire.